| |
| |
|
| Insider
Information: |
Moore John R |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
5,415 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$139,946 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,415 |
|
|
| Total
Value |
$139,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alpine Immune Sciences Inc |
ALPN |
Director |
2015-06-16 |
2,163 |
|
0 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
|
2024-05-02 |
3,252 |
2021-12-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-05-02 |
4 |
S |
$18.91 |
$36,988 |
D/D |
(1,956) |
3,252 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
5,208 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-02-09 |
4 |
AS |
$20.01 |
$160,657 |
D/D |
(8,029) |
0 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-02-09 |
4 |
OE |
$1.93 |
$15,496 |
D/D |
8,029 |
8,029 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-02-08 |
4 |
OE |
$1.93 |
$7,359 |
D/D |
3,813 |
3,813 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-02-08 |
4 |
AS |
$20.01 |
$76,285 |
D/D |
(3,813) |
0 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-02-07 |
4 |
OE |
$1.93 |
$34,726 |
D/D |
17,993 |
17,993 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2024-02-07 |
4 |
AS |
$20.00 |
$359,864 |
D/D |
(17,993) |
0 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2023-12-27 |
4 |
AS |
$10.50 |
$89,219 |
D/D |
(8,497) |
0 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2023-05-02 |
4 |
S |
$8.90 |
$16,893 |
D/D |
(1,897) |
6,565 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2023-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
8,462 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-10-03 |
4 |
OE |
$1.93 |
$9,129 |
D/D |
4,730 |
7,730 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-10-03 |
4 |
AS |
$9.76 |
$46,155 |
D/D |
(4,730) |
3,000 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-09-06 |
4 |
AS |
$10.83 |
$51,598 |
D/D |
(4,730) |
3,000 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-09-06 |
4 |
OE |
$1.93 |
$9,129 |
D/D |
4,730 |
7,730 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-08-03 |
4 |
AS |
$9.31 |
$85,921 |
D/D |
(9,232) |
3,000 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-08-03 |
4 |
OE |
$0.71 |
$12,325 |
D/D |
9,232 |
12,232 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-07-06 |
4 |
OE |
$1.93 |
$2,019 |
D/D |
1,046 |
4,046 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-07-06 |
4 |
AS |
$8.54 |
$8,928 |
D/D |
(1,046) |
3,000 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-07-05 |
4 |
AS |
$8.35 |
$68,329 |
D/D |
(8,186) |
3,000 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-07-05 |
4 |
OE |
$0.71 |
$10,307 |
D/D |
8,186 |
11,186 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-06-21 |
4 |
OE |
$0.71 |
$43,501 |
D/D |
31,078 |
34,078 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-06-21 |
4 |
AS |
$7.29 |
$226,695 |
D/D |
(31,078) |
3,000 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-06-17 |
4 |
AS |
$6.62 |
$146,434 |
D/D |
(22,127) |
3,000 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
General Counsel |
• – – |
2022-06-17 |
4 |
OE |
$1.93 |
$42,705 |
D/D |
22,127 |
25,127 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
